Cours Innovus Pharmaceuticals Inc Other OTC
Actions
US45778V1061
Produits pharmaceutiques
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Joshua Disbrow
CEO | Chief Executive Officer | 49 | - |
Chief Operating Officer | - | 01/06/18 | |
Steven Klayman
PRN | Corporate Officer/Principal | - | - |
Varia. 1 janv. | Capi. | |
---|---|---|
+32,09% | 694 Md | |
+29,39% | 593 Md | |
-1,34% | 371 Md | |
+20,34% | 331 Md | |
+7,39% | 290 Md | |
+14,25% | 239 Md | |
-3,03% | 209 Md | |
+10,02% | 209 Md | |
+8,49% | 169 Md |